Send the following on WhatsApp
Continue to Chathttps://www.marketscreener.com/quote/stock/ANAPTYSBIO-INC-33634949/news/AnaptysBio-Announces-Positive-ANB032-anti-BTLA-agonist-Top-Line-Phase-1-Data-and-Provides-Pipeline-40174260/?utm_source=whatsapp&utm_medium=social&utm_campaign=share